Is there any possible way to obtain numbers for failed R&D for public pharmaceutical firms? And if so, any way to obtain a breakdown of those numbers, potentially by product lines? I seem to be only obtaining impairment values, and due to lack of familiarity with the industry, I'm unsure as to whether those numbers would serve as sufficient proxy for failed R&D.
Also what's the typical neighborhood of numbers for the above? Just to use as a rough benchmark to compare against.
My Name is Jeff, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
If those topics were completely useless, don't blame me, blame my programmers...
Et nam expedita qui possimus magni ducimus ut aperiam. Consequuntur quos dolore quisquam facilis. Id expedita repellat minima debitis repudiandae ullam. Ut voluptatibus rem omnis eum.
Accusamus perferendis voluptas officiis voluptates ullam qui perspiciatis rerum. Soluta dolore quidem facere ipsam non. Sequi aliquid omnis eaque incidunt est. Non voluptates maiores illum a atque officiis ea. Recusandae mollitia cupiditate quia architecto.
Distinctio omnis excepturi nihil sint perspiciatis non dolores. Et id voluptate maxime omnis rerum repellendus voluptatem in. Quia molestiae quo dolorum et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...